The Burbank, California-based non-profit phaware is a global association dedicated to creating awareness about pulmonary hypertension through engagement and technological innovation…
Articles by Charles Moore
The American Heart Association (AHA) and American Thoracic Society (ATS) have issued new guidelines pertaining to Pediatric Pulmonary Hypertension. The…
Dublin, Ireland, based biopharmaceutical company Mallinckrodt plc reports that its INOmax (nitric oxide) vasodilator inhalation device has received…
Irving, Texas-based Reata Pharmaceuticals, Inc. announced initial data from the LARIAT (A Dose-Ranging Study of the Efficacy and…
October 13 is World Thrombosis Day, an event that increases global awareness and focuses attention on the often overlooked and…
Launching today, the Burbank, California-based phaware global association (phaware) is a new non-profit organization and…
Revised international treatment guidelines for Idiopathic Pulmonary Fibrosis (IPF) suggest use of OFEV (nintedanib), a proprietary drug from Ingelheim,…
Inhaled nitric oxide (NO) is a proven life-saving therapy for newborns, children and adults with several dangerous conditions, including Pulmonary…
The Mayo Clinic’s Jacksonville, Florida unit and Silver Spring, Maryland-based biotechnology company United Therapeutics Corporation have announced that…
Affecting more than 80 million Americans each year, poor sleep quality has been associated with increased risks of stroke, dementia,…
The U.K.’s Chancellor of the Exchequer, George Osborne, has announced that the University of Sheffield will be awarded £7.5…
A team of researchers at the University of Pennsylvania and the University of Florida have identified a…